IGF-1 LR3


IGF-1 LR3 is a modified form of insulin-like growth factor 1 studied for its interaction with IGF-1 receptors and its reduced binding to IGF-binding proteins. Research on this molecule has primarily used laboratory and animal models. DeSoto Peptides is developing batch-specific documentation to support verification of its research materials.

Digital illustration of a medical vial with a blue cross label and a blue cap.

1MG PER VIAL

Lyophilized research material

Digital illustration of a microscope with a blue and white color scheme.

RESEARCH GRADE

Lot-specific documentation available

A shield icon with a checkmark in the center, symbolizing security or protection.

BATCH VERIFIED

For laboratory research only

ONE GROWTH SIGNAL. A MODIFIED RESEARCH MOLECULE.

HOW IGF-1 LR3 IS STUDIED

IGF-1 LR3 is a modified version of IGF-1. Researchers use it to study IGF-1 receptor signaling and how reduced binding to IGF-binding proteins changes its activity in laboratory models.

Illustration of the IGF-1 receptor in a cell membrane showing detailed molecular structure and signaling pathway.

Interacts with a receptor involved in cell growth signaling.

Illustration of molecular structures with the text "Reduced Protein Binding" at the top.

Binds less strongly to proteins that normally carry and regulate

Illustration of a cell with molecules and particles, depicting cellular response.

Used in laboratory studies of how cells respond to signals.

WHAT THE RESEARCH SHOWS

IGF-1 LR3 research has mainly used cultured cells and animals. In a cell study, it activated IGF-1 receptors at lower concentrations than native IGF-1. That shows activity in the laboratory; it does not establish a benefit in people.

In a seven-day guinea pig study, IGF-1 LR3 increased the relative weight of several organs, but overall body growth did not increase. That distinction should stay visible in the research cards.

Research poster with neon blue border, titled 'IGF-1 LR3 RESEARCH' in large text. Subsections titled 'Protein Binding', 'Cell Signaling', and 'Animal Model' with descriptions of experiments on IGF-1 LR3 in cell and animal studies.
Neon sign stating '1,000x LOWER BINDING AFFINITY to IGF-binding proteins compared with native IGF-1 in lab assays' in blue and white text on a black background.
Neon sign displaying '7 DAYS GUINEA PIG STUDY' with additional text about organ weight and body growth.
Neon sign displaying peer-reviewed research in endocrinology, molecular biotechnology, and journal of endocrinology with years 2001, 2006, and 1995.
A digital screen displaying a scientific research article citation with a glowing blue border on a black background.
A digital screen displaying a scientific research article citation with a glowing blue border on a black background.

IGF-1 LR3 1MG

Research material with batch-specific documentation.

For research use only. Not for human consumption